神經診斷市場規模、佔有率和成長分析（按產品、疾病狀況、最終用戶和地區）- 產業預測 2025-2032

2023 年神經診斷市場規模價值 99 億美元，預計將從 2024 年的 107.9 億美元成長到 2032 年的 215 億美元，預測期間（2025-2032 年）的複合年成長率為 9.0%。

由於神經系統疾病發病率上升、人口老化和技術進步，神經診斷市場正在經歷顯著成長。早期和準確疾病檢測的技術創新，特別是神經退化性疾病的檢測，正在透過蛋白質組學和基因組學的整合來提高診斷的準確性。全球醫院和診斷中心數量的不斷增加，提高了人們獲取先進診斷技術的管道，進一步推動了市場擴張。神經診斷中對生物學分析的需求也日益增加。但挑戰依然存在，包括嚴格的法規和發展中地區有限的需求。儘管如此，神經診斷藥物在臨床研究中的應用快速成長以及新興經濟體中尚未開發的潛力表明其前景光明。預計未來幾年美國神經診斷市場將保持顯著成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

神經診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 診斷和影像系統
  • 腦電圖 (EEG) 系統
  • 肌電圖 (EMG) 產品
  • 磁振造影(MRI) 系統
  • 超音波影像系統
  • 電腦斷層掃描 (CT) 掃描儀
  • 腦磁圖 (MEG) 系統
  • 正子斷層掃描（PET）系統
  • 血管造影術系統
  • 其他系統
• 臨床檢測設備
  • PCR
  • 次世代定序（NGS）
  • 桑格定序
  • 其他臨床診斷產品
• 試劑和耗材
  • 培養基和血清
  • 溶劑
  • 酵素 蛋白質 多胜肽
  • 探測
  • 緩衝
  • 抗體
  • 其他試劑

神經診斷藥物市場規模（按病理學和複合年成長率） (2025-2032)

• 市場概況
• 神經退化性疾病
• 癲癇
• 中風
• 頭痛症
• 睡眠障礙
• 其他條件

神經診斷市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院和外科中心
• 神經內科中心
• 門診治療中心
• 診斷實驗室和影像中心
• 研究辦公室和學術機構

神經診斷市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（US）
• GE Healthcare（US）
• Koninklijke Philips（Netherlands）
• FUJIFILM（Japan）
• Lifelines Neuro（US）
• Advanced Brain Monitoring（US）
• Nihon Kohden（Japan）
• Hoffmann-La Roche（Switzerland）
• Canon Medical Systems（Japan）
• Danaher（US）
• Abbott Laboratories（US）
• Becton, Dickinson and Company（BD）（US）
• Johnson & Johnson（US）
• Medtronic（Ireland）
• Stryker（US）
• Intuitive Surgical（US）
• Zimmer Biomet（US）
• Smith & Nephew（UK）

結論和建議

Neurodiagnostics Market size was valued at USD 9.9 billion in 2023 and is poised to grow from USD 10.79 billion in 2024 to USD 21.5 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The neurodiagnostic market is witnessing significant growth driven by rising rates of neurological disorders, an aging population, and advancements in technology. Innovations in early and accurate disease detection, particularly for neurodegenerative conditions, are enhancing diagnostic precision through the integration of proteomics and genomics. The increasing number of hospitals and diagnostic centers worldwide is further promoting market expansion as access to advanced diagnostic technology improves. Demand for biological profiling in neurological diagnoses is also increasing. However, challenges remain, including stringent regulations and limited demand in developing regions. Nevertheless, the burgeoning application of neurodiagnostics in clinical studies and the untapped potential in emerging economies indicate a promising future. The US neurodiagnostics market is projected to sustain substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurodiagnostics Market Segments Analysis

Global Neurodiagnostics Market is segmented by Product, Condition, End-User and region. Based on Product, the market is segmented into Diagnostic and Imaging Systems, Clinical Testing Instruments and Reagents & Consumables. Based on Condition, the market is segmented into Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Diseases. Based on End-User, the market is segmented into Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurodiagnostics Market

The neurodiagnostics market is experiencing significant growth primarily due to the rising prevalence of neurological disorders, including epilepsy, Parkinson's disease, and Alzheimer's disease. As the number of individuals affected by these conditions continues to rise, there is an increasing demand for advanced diagnostic technologies within healthcare settings. This trend has led to a greater adoption of neurodiagnostic tools and instruments, as healthcare providers seek sophisticated solutions to accurately identify and monitor these disorders. Consequently, the market is expanding as stakeholders respond to the urgent need for effective diagnostic methodologies in the face of escalating neurological health challenges.

Restraints in the Neurodiagnostics Market

A significant obstacle in the neurodiagnostics market is the stringent regulations governing the approval and marketing of neurodiagnostic devices. These lengthy procedures and intricate guidelines can hinder innovation and postpone the launch of new technologies. Such delays adversely affect the overall expansion of the neurodiagnostics sector, especially in regions with rigorous healthcare regulations. As a result, the potential for technological advancements is stifled, making it challenging for companies to introduce innovative solutions promptly, ultimately limiting the market's growth and accessibility of neurodiagnostic services for patients who could benefit from them.

Market Trends of the Neurodiagnostics Market

The neurodiagnostics market is increasingly influenced by the advancements in genomics and personalized medicine, which are revolutionizing the approach to diagnosing and treating neurological disorders. As healthcare providers leverage genetic profiling and proteomic data, they can tailor treatments to individual patients, significantly improving therapeutic outcomes. This trend is driving demand for advanced diagnostic tools that enable precise identification of underlying genetic factors contributing to neurological conditions. Consequently, the market is witnessing a shift towards sophisticated techniques such as next-generation sequencing and high-throughput screening, enhancing the overall efficacy and personalization of patient care within the neurodiagnostic landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Neurodiagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Diagnostic and Imaging Systems
  • Electroencephalogram (EEG) Systems
  • Electromyography (EMG) Products
  • Magnetic Resonance Imaging (MRI) Systems
  • Ultrasound Imaging Systems
  • Computed Tomography (CT) Scanner
  • Magnetoencephalogram (MEG) System
  • Position emission tomography (PET) System
  • Angiography System
  • Other Systems
• Clinical Testing Instruments
  • PCR
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Other Clinical Diagnostic Products
• Reagents & Consumables
  • Media and Serra
  • Solvents
  • Enzymes, Protein & Peptides
  • Probes
  • Buffers
  • Antibodies
  • Other Reagents

Global Neurodiagnostics Market Size by Condition & CAGR (2025-2032)

• Market Overview
• Neuro Degenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders
• Other Diseases

Global Neurodiagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

Global Neurodiagnostics Market Size & CAGR (2025-2032)

• North America (Product, Condition, End-User)
  • US
  • Canada
• Europe (Product, Condition, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Condition, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Condition, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Condition, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifelines Neuro (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Brain Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations